PDPK1 anticorps (AA 1-429)
Aperçu rapide pour PDPK1 anticorps (AA 1-429) (ABIN518765)
Antigène
Voir toutes PDPK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-429
-
Fonction
- Mouse polyclonal antibody raised against a full-length human PDPK1 protein.
-
Séquence
- MARTTSQLYD AVPIQSSVVL CSCPSPSMVR TQTESSTPPG IPGGSRQGPA MDGTAAEPRP GAGSLQHAQP PPQPRKKRPE DFKFGKILGE GSFSTVVLAR ELATSREYAT RANSFVGTAQ YVSPELLTEK SACKSSDLWA LGCIIYQLVA GLPPFRAGNE YLIFQKIIKL EYDFPEKFFP KARDLVEKLL VLDATKRLGC EEMEGYGPLK AHPFFESVTW ENLHQQTPPK LTAYLPAMSE DDEDCYGNYD NLLSQFGCMQ VSSSSSSHSL SASDTGLPQR SGSNIEQYIH DLDSNSFELD LQFSEDEKRL LLEKQAGGNP WHQFVENNLI LKMGPVDKRK GLFARRRQLL LTEGPHLYYV DPVNKVLKGE IPWSQELRPE AKNFKTFFVH TPNRTYYLMD PSGNAHKWCR KIQEVWRQRY QSHPDAAVQ
-
Réactivité croisée
- Humain, Souris
-
Attributs du produit
- Antibody reactive against mammalian transfected lysate.
-
Immunogène
- PDPK1 (NP_112558.2, 1 a.a. ~ 429 a.a) full-length human protein.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma." dans: Molecular & cellular proteomics : MCP, Vol. 12, Issue 5, pp. 1335-49, (2013) (PubMed).
-
-
- PDPK1 (3-phosphoinositide Dependent Protein Kinase-1 (PDPK1))
-
Autre désignation
- PDPK1
-
Sujet
-
Full Gene Name: 3-phosphoinositide dependent protein kinase-1
Synonyms: MGC20087,MGC35290,PDK1,PRO0461 -
ID gène
- 5170
-
NCBI Accession
- NM_031268
-
Pathways
- Signalisation PI3K-Akt, TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Regulation of Cell Size, Skeletal Muscle Fiber Development, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Antigène
-